NOVARTIS AG (NY: NVS)
84.70 USD  +0.03 (+0.04%)
Streaming Delayed Price  /  Updated: 10:37 AM EDT, Apr 21, 2014  /  Add to My Watchlist      
(NVS) Community Analysis from
April 21, 2014
(Jutia Group, 12/3/13)
[at Bloomberg] - Novartis AG’s animal-health business is drawing interest from drugmakers including Eli Lilly & Co. and Merck &...(read more)
(Jutia Group, 12/3/13)
[at Bloomberg] - Novartis AG’s animal-health business is drawing interest from drugmakers including Eli Lilly & Co. and Merck & Co. as the...(read more)
(Stock Blog Hub, 7/23/13)
Novartis (NVS) recently announced positive results on Afinitor, from a phase III trial, BOLERO-3. The study is evaluating Novartis’ Afinitor plus Roche’s (RHHBY) Herceptin and...(read more)
Novartis AG (NVS) Company Overview

There is no analysis for NVS yet. But you can go to Wikinvest to help create one!


Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here